Effect of Shockwave Therapy on Post-laminectomy Fibrosis Low Back Pain Patients. (SWT)

May 31, 2023 updated by: Marwa Mohamed Hany Sedeek Abousenna

Effect of Shock Wave Therapy on Low Back Pain and Sciatica in Patients With Post-laminectomy Fibrosis

The aim of this study is clinical trial to investigate the effect of Radial Extracorporeal Shock wave therapy in patients with sciatica and low back pain caused by post laminectomy scarring. the study will answer the following question:

1. what is the effect of Shock Wave Therapy on low back pain and sciatica caused by post-laminectomy fibrosis? patients in the study group will receive radial extracorporeal shock wave therapy and conventional physical therapy program (TENS, electric heating packs, and McKenzie back exercises).

Study Overview

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Recruited patients will be diagnosed by neurosurgeon as sciatic pain and low back pain caused by post laminectomy scarring.
  2. Both genders will be recruited.
  3. Their age will range from: 30-50 years (Sharaf, et al., 2022).
  4. Recruited patients will be randomly assigned in to two equal groups.
  5. Unilateral radicular sciatica.
  6. Constant back pain OR aggravated by movement,
  7. Restricted lumbar range of motion.
  8. Tenderness at the site of incision.
  9. Duration of symptoms: three weeks to six months postoperatively

Exclusion Criteria:

  1. Past history of vertebral fracture.
  2. Spinal cord compression.
  3. Vertebral tuberculosis.
  4. Polyneuropathy.
  5. Diabetic peripheral neuropathy.
  6. Spinal tumor.
  7. Recurrent disc herniation after surgery.
  8. Spondylolisthesis.
  9. Vascular diseases, e.g., peripheral vascular diseases, coronary artery bypass graft and coagulation diseases.
  10. Potential pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: controlled
thirty patients will receive conventional physical therapy program (TENS, electric heating packs, and McKenzie back exercises).
EME (Therapic 9400) TENS
Graduated Progressive back exercise program.
electrical conducting heat pack.
Active Comparator: shock wave therapy
thirty patients will receive radial extracorporeal shock wave therapy and conventional physical therapy program (TENS, electric heating packs, and McKenzie back exercises).
EME (Therapic 9400) TENS
Graduated Progressive back exercise program.
electrical conducting heat pack.
Shock wave therapy: (BECO) S/N 16B011375

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analogue Scale (VAS)
Time Frame: 4 weeks
The VAS consisted of a 10 cm horizontal line with the description "no pain" on the far left and "worst possible pain" on the far right
4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain algometry
Time Frame: 4 weeks
PainTest™ FPX 25 Algometer (Wagner Instruments, Greenwich, USA)
4 weeks
Lumbar Range Of Motion
Time Frame: 4 weeks
The BROM II
4 weeks
The Oswestry Disability Index: (ODI)
Time Frame: 4 weeks
The Oswestry disability index is a self-completed, valid tool with adequate reliability to identify changes in functional disability
4 weeks
Sensory Nerve Conduction Study (NCS)
Time Frame: 4 weeks
Sensory nerve action potentials (sensory nerve amplitude)
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2023

Primary Completion (Estimated)

January 1, 2024

Study Completion (Estimated)

May 1, 2024

Study Registration Dates

First Submitted

April 28, 2023

First Submitted That Met QC Criteria

May 31, 2023

First Posted (Actual)

June 2, 2023

Study Record Updates

Last Update Posted (Actual)

June 2, 2023

Last Update Submitted That Met QC Criteria

May 31, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • P.T.REC/012/004382

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The IPD will be free to share within 6 months to 1 year after publication.

IPD Sharing Time Frame

6 months to 1 year after publication.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post-laminectomy Syndrome

Clinical Trials on Transcutaneous Electrical Nerve Stimulation (TENS)

Subscribe